PML and ANKRD2

  • Number of citations of the paper that reports this interaction (PMID 15136035)
  • 34
  • Data Source:
  • HPRD (in vitro, in vivo)

PML

ANKRD2

Gene Name promyelocytic leukemia ankyrin repeat domain 2 (stretch responsive muscle)
Image No pdb structure
Gene Ontology Annotations Cellular Component
Molecular Function
Biological Process
Pathways
Drugs
Diseases
GWAS
Protein-Protein Interactions 101 interactors: ADH1B ANKRD2 ARID3A ARNT ATF2 ATXN1 AURKA AXIN1 BANP BCL2 BCL6 CASP8AP2 CCNT1 CDK1 CDK2 CDK6 CHFR CREBBP CSNK2A1 DAXX EGFR EIF4E ELF4 EP300 FOS GATA2 HDAC1 HDAC2 HDAC3 HHEX HIPK2 HTT KAT5 KAT6A MAPK11 MAPK14 MDM2 MED7 MXD1 MYB MYC NCOA2 NCOR1 NCOR2 NFKB1 NR3C1 NR4A1 PAWR PAXIP1 PCBD2 PIAS1 PIAS2 PIN1 PLAGL1 PLSCR1 POLR2E PPARG PSMA3 RARA RB1 RBX1 RELA RNF111 RNF125 RNF4 RPL11 RXRA SENP2 SH3GL1 SIAH2 SIN3A SIRT1 SKI SMAD3 SP1 SP100 SRF STAT3 SUMO1 SUMO2 SUMO3 SUV39H1 SYNE2 TDG TERF2IP TGFBR1 TGFBR2 TGIF1 THRA TOPBP1 TP53 TP63 TP73 TRIM24 TRIM27 TRIM69 UBE2I UBE2U UBE3A ZBTB16 ZFYVE9 8 interactors: FAIM3 HBP1 PML TCAP TP53 TTN YBX1 ZBTB3
Entrez ID 5371 26287
HPRD ID 00023 12460
Ensembl ID ENSG00000140464 ENSG00000165887
Uniprot IDs P29590 Q9GZV1
PDB IDs 1BOR
Enriched GO Terms of Interacting Partners?
Tagcloud ?
anthracycline  apl  approaches  appropriately  arsenic  corepressors  curable  cure  deacetylase  effectiveness  explain  explains  incorporation  minority  oncogenes  pathogenetic  plzf  progranulocytic  promoters  ra  rar  recruit  refinement  relapsed  repression  safe  timed  trioxide  vast 
a165v  a171t  actinin2  alternatively  cardiomyopathy  compaction  competition  cypher  cytoskeletal  differs  dilated  homologue  indication  lethality  lim  mechanosensing  motif  multiprotein  myofibrillar  myopathy  nomenclature  pdz  sarcomeres  spliced  striated  sumoylation  zasp  zaspopathy  zm 
Tagcloud (Difference) ?
anthracycline  apl  approaches  appropriately  arsenic  corepressors  curable  cure  deacetylase  effectiveness  explain  explains  incorporation  minority  oncogenes  pathogenetic  plzf  progranulocytic  promoters  ra  rar  recruit  refinement  relapsed  repression  safe  timed  trioxide  vast 
a165v  a171t  actinin2  alternatively  cardiomyopathy  compaction  competition  cypher  cytoskeletal  differs  dilated  homologue  indication  lethality  lim  mechanosensing  motif  multiprotein  myofibrillar  myopathy  nomenclature  pdz  sarcomeres  spliced  striated  sumoylation  zasp  zaspopathy  zm 
Tagcloud (Intersection) ?